Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cell glucose deprivation tolerance describes the ability of cancer cells to survive and adapt to conditions of low glucose. This involves metabolic reprogramming, enhanced antioxidant defenses, and activation of stress response pathways to maintain ATP levels and mitigate oxidative stress, ultimately contributing to drug resistance and tumor progression.
N/A - This is a cellular phenotype, not a single molecule.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer Cell Glucose Deprivation Tolerance (GD Tolerance).